Author: Justin D Silverman; Alex D Washburne
Title: Using ILI surveillance to estimate state-specific case detection rates and forecast SARS-CoV-2 spread in the United States Document date: 2020_4_3
ID: 17oac3bg_10
Snippet: The true prevalence of SARS-CoV-2 is unknown. However, if we assume the excess non-influenza ILI is almost entirely due to SARS-CoV-2, an assumption that becomes more valid as the virus becomes more prevalent, we can use the excess non-influenza ILI to define bounds and understand 110 the mutual dependence of exponential growth rates, the rate of subclinical infections, and the time between the onset of infectiousness and a patient reporting as I.....
Document: The true prevalence of SARS-CoV-2 is unknown. However, if we assume the excess non-influenza ILI is almost entirely due to SARS-CoV-2, an assumption that becomes more valid as the virus becomes more prevalent, we can use the excess non-influenza ILI to define bounds and understand 110 the mutual dependence of exponential growth rates, the rate of subclinical infections, and the time between the onset of infectiousness and a patient reporting as ILI Figure 3 . With a January 15 start date of the US epidemic [10] , allowing early stochasticity from start-time to the onset of regular exponential growth, we find that it's impossible to explain the ILI surge with an epidemic whose doubling time is longer than 3.5-days, as such slow growth scenarios fail to produce enough 115 infected individuals to match the observed excess ILI.
Search related documents:
Co phrase search for related documents- doubling time and exponential growth: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- doubling time and exponential growth rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- doubling time and growth rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- doubling time and ILI surge: 1, 2, 3, 4, 5
- doubling time and ILI surge explain: 1, 2
- doubling time and infected individual: 1, 2, 3, 4, 5, 6, 7, 8
- doubling time and infectiousness onset: 1, 2, 3, 4
- doubling time and SARS true prevalence: 1
- early stochasticity and exponential growth: 1
- epidemic start date and exponential growth: 1, 2, 3
- epidemic start date and exponential growth rate: 1, 2, 3
- epidemic start date and growth rate: 1, 2, 3
- exponential growth and growth rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- exponential growth and growth scenario: 1, 2, 3, 4, 5, 6, 7, 8, 9
- exponential growth and ILI surge: 1
- exponential growth and infected individual: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- exponential growth and infectiousness onset: 1, 2
- exponential growth and mutual dependence: 1
- exponential growth and patient reporting: 1
Co phrase search for related documents, hyperlinks ordered by date